NCT00412503View on ClinicalTrials.gov

Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Refractory TumorsMalignant Tumors

Interventions

DRUG

Topotecan, Temozolomide

Trial Locations (1)

94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors

lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER